Research & Innovation - Participant Portal

TOPIC : Implementing the Strategic Research Agenda on Personalised Medicine

Topic identifier: SC1-HCO-03-2017
Publication date: 14 October 2015

Types of action: ERA-NET-Cofund ERA-NET Cofund
DeadlineModel:
Opening date:
single-stage
28 July 2016
Deadline: 11 April 2017 17:00:00

Time Zone : (Brussels time)
  Horizon 2020 H2020 website
Pillar: Societal Challenges
Work Programme Year: H2020-2016-2017
Topic Updates
  • 13 January 2017 09:38

     Please note that Switzerland is now officially associated to the Horizon SC1 as well. Swiss participants are therefore eligible to receive Horizon 2020 SC1 support. Please see details in the note here.

Topic Description
Specific Challenge:

By providing the right intervention to the right person at the right time, personalised medicine[1] can improve quality of life and contribute to more sustainable healthcare at Member State level. It may drive new and faster development processes and products, providing European life sciences industries with a competitive edge that can secure growth and jobs. Today, development is uneven across and within sectors, regions and Member States due to fragmented activities, insufficient communication and lack of commonly accepted solutions and standards.

The FP7 funded coordination and support action "Personalised Medicine 2020 and beyond – Preparing Europe for leading the global way (PerMed)[2]" was launched in 2013 with the objective to develop a Strategic Research Agenda to progress personalised medicine in Europe. PerMed partners have strived to focus their strategy on concrete research actions, many of which should be addressed through transnational collaborative health research.

An ERA-NET Cofund action is therefore a suitable and timely tool to implement relevant parts of PerMed's Strategic Research and Innovation Agenda[3], which will be published in 2015.

Scope:

Proposals should pool the necessary financial resources from the participating national (or regional) research programmes with a view to implementing a joint call for proposals resulting in grants to third parties with co-funding in this area.

This call should aim at implementing a key area of the PerMed Strategic Research Agenda and be complementary with other funding programmes and activities at European and international level. Proposers are encouraged to include other joint activities including additional joint calls without EU co-funding. This work should be informed by the output of the coordination and support action envisaged in topic SC1-HCO-05-2016 - Coordinating personalised medicine research, without duplicating any of its work.

The proposed ERA-NET should demonstrate the expected impact on national and transnational programmes as well as the leverage effect on European research and competitiveness, and should plan the development of key indicators for supporting this. Participation of international partners is highly encouraged.

The Commission considers that a proposal requesting a contribution from the EU of EUR 5 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Expected Impact:
  • Deepened and extended coordination of national and transnational research in the field of personalised medicine.
  • Streamlined national/regional and international practices in organising research funding.
  • Increased interoperability of national research programmes.
  • Increased sharing of data and knowledge.
  • Increased networking of infrastructures and databases such as ESFRI infrastructures
Cross-cutting Priorities:

International cooperation
Gender
Socio-economic science and humanities

[1]Personalised medicine refers to a medical model using characterization of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention. The term "personalised medicine" is used throughout this Work Programme with this definition in mind.

[2]www.permed2020.eu

[3]Available at http://www.permed2020.eu/1428.php

Topic conditions and documents

Please read carefully all provisions below before the preparation of your application.
 

  1. List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
    Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in some Horizon 2020 topics (to check funding conditions, follow the links to Australia, BrazilCanada, China, Hong Kong & Macau, IndiaJapan, Republic of Korea, Mexico, Russia, Taiwan, USA*).
    *Note that US participants in projects under the Horizon 2020 "Health, Demographic Change and Wellbeing" Societal Challenge are automatically eligible for EU-funding according to the provisions in the relevant work programme

     
  2. Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.

    Proposal page limits and layout: Please refer to Part B of the standard proposal template.

     
  3. Evaluation

    3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.

    3.2 Submission and evaluation process: Guide to the submission and evaluation process

          
  4. Indicative timetable for evaluation and grant agreement:

    Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
    Signature of grant agreements: maximum 8 months from the deadline for submission.

     
  5. Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:

    ERANET Cofund:

    Specific provisions and funding rates
    Standard proposal template
    Standard evaluation form
    H2020 MGA ERANET Cofund - Multi-Beneficiary
    Annotated Grant Agreement

    Essential information for clinical studies

     
  6. Additional provisions:

    Horizon 2020 budget flexibility
    Classified information
    Financial support to Third Parties – where a topic description foresees financial support to Third Parties, these provisions apply.

     
  7. Open access must be granted to all scientific publications resulting from Horizon 2020 actions.

    Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.

    Open access to research data
    The Open Research Data Pilot has been extended to cover all Horizon 2020 topics for which the submission is opened on 26 July 2016 or later. Projects funded under this topic will therefore by default provide open access to the research data they generate, except if they decide to opt-out under the conditions described in annex L of the Work Programme. Projects can opt-out at any stage, that is both before and after the grant signature.

    Note that the evaluation phase proposals will not be evaluated more favourably because they plan to open or share their data, and will not be penalised for opting out.

    Open research data sharing applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available open access and need to describe their approach in a Data Management Plan.

    - Projects need to create a Data Management Plan (DMP), except if they opt-out of making their research data open access. A first version of the DMP must be provided as an early deliverable within six months of the project and should be updated during the project as appropriate. The Commission already provides guidance documents, including a template for DMPs.

    - Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration.

    The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.


     

  8. Additional documents:

    H2020 Work Programme 2016-17: Health, demographic change and wellbeing

    H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation

    H2020 Work Programme 2016-17: General Annexes

    Legal basis: Horizon 2020 - Regulation of Establishment

    Legal basis: Horizon 2020 Rules for Participation

    Legal basis: Horizon 2020 Specific Programme

 

Additional documents

Download all documents
(EN only, incl. the additional docs.)

Submission Service

The submission system is planned to be opened on the date stated on the topic header.

Type of Action ERA-NET Cofund [ERA-NET-Cofund]
Topic Implementing the Strategic Research Agenda on Personalised Medicine - SC1-HCO-03-2017
Guidance on proposal submission: H2020 online manual
IT Guidance: IT help

Get support

H2020 Online Manual your online guide on the procedures from proposal submission to managing your grant.

Participant Portal FAQ – Submission of proposals.

National Contact Points (NCP) - 
contact your NCP for further assistance.

Research Enquiry Service
– ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

Enterprise Europe Network
– contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

IT Helpdesk
- contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

Contact the EIT for further assistance related to the call, topics and the content of proposals via the Contact Page on the EIT website.

Clean Sky 2 National Contact Points
- Clean Sky 2 JU States Representative Group

Clean Sky 2 Helpdesk:
Info-Call-CPW-2014-01@Cleansky.EU

ECSEL National Contact Points
– consult Annex G of the ECSEL Work Plan

ECSEL Helpdesk:
setupecsel@ecsel.europa.eu

IMI States Representative Group (SRG)
– contact you SRG member for assistance.

IMI JU IT Helpdesk
– for IMI2 topics contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

Shift2Rail Call Helpdesk: info-call@shift2rail.europa.eu

Ethics
– for compliance with ethical issues, see the Participant Portal and Science and Society Portal

European IPR Helpdesk
assists you on intellectual property issues

CEN
and CENELEC, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at research@cencenelec.eu.

The European Charter for Researchers and the Code of Conduct for their recruitment


Partner Search Services
help you find a partner organisation for your proposal

IMI Partner Search Tool
helps you find a partner organisation for your proposal